Reduced Lymphoid Lineage Priming Promotes Human Hematopoietic Stem Cell Expansion

•ID2-mediated inhibition of E47 activity controls human HSC lineage commitment•ID2 OE reduces lymphoid priming and increases myeloid and stemness programs in HSC•Attenuation of lymphoid differentiation genes in HSC increases self-renewal

SummaryThe hematopoietic system sustains regeneration throughout life by balancing self-renewal and differentiation. To stay poised for mature blood production, hematopoietic stem cells (HSCs) maintain low-level expression of lineage-associated genes, a process termed lineage priming. Here, we modulated expression levels of Inhibitor of DNA binding (ID) proteins to ask whether lineage priming affects self-renewal of human HSCs. We found that lentiviral overexpression of ID proteins in cord blood HSCs biases myeloerythroid commitment at the expense of lymphoid differentiation. Conversely, reducing ID2 expression levels increases lymphoid potential. Mechanistically, ID2 inhibits the transcription factor E47 to attenuate B-lymphoid priming in HSCs and progenitors. Strikingly, ID2 overexpression also results in a 10-fold expansion of HSCs in serial limiting dilution assays, indicating that early lymphoid transcription factors antagonize human HSC self-renewal. The relationship between lineage priming and self-renewal can be exploited to increase expansion of transplantable human HSCs and points to broader implications for other stem cell populations.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (218 K)Download as PowerPoint slide